FDA’s new expert panels are rife with financial conflicts and fringe views
By MATTHEW PERRONE, AP Health Writer WASHINGTON (AP) — When the Food and Drug Administration needs outside guidance, it normally turns to a trusted source: a large roster of expert advisers who are carefully vetted for their independence, credentials and … Continued